Boardroom Alpha
Boardroom Alpha
AROW · Amended Annual Report (Form 10-K/A) · Filed March 27, 2026

Arrow Financial Corp — Amended Annual Report (Form 10-K/A)

Form
10-K/A
Filed
March 27, 2026
Period
Dec 31, 2025
Ticker
AROW
Accession
0000717538-26-000041
About Arrow Financial Corp
Market cap
$611M
1Y TSR
+46.7%
3Y TSR
+27.0%
Board grade
C+
Sector
Financial Services
CEO
David S Demarco
Last annual meeting: Jun 3, 2026 · View full Arrow Financial Corp profile →
arow-20251231

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K/A
Amendment No. 1
☒ Annual Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

For the Fiscal Year Ended December 31, 2025
☐ Transition Report Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934

Commission File Number: 0-12507

ARROW FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
New York22-2448962
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
250 Glen Street, Glens FallsNew York12801
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code:   518745-1000

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Each Exchange on Which Registered
Common Stock, Par Value $1.00 per share
AROWNASDAQ Global Select Market
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   Yes      No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes      No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes     No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by a check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7562(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter:    $426,347,636
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
ClassOutstanding as of February 27, 2026
Common Stock, par value $1.00 per share16,511,643
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrant’s Proxy Statement for Annual Meeting of Shareholders to be held June 3, 2026 are incorporated by reference into Part III of this Form 10-K.

Auditor Name: Crowe LLP         Auditor Location: Indianapolis, Indiana         Auditor Firm ID: 173        




EXPLANATORY NOTE

This Amendment No. 1 to the Annual Report on Form 10-K (this “Amendment”) amends the Annual Report on Form 10-K for the year ended December 31, 2025, originally filed on March 6, 2026 (the “Original Filing”) by Arrow Financial Corporation ("Arrow" or the “Company”). Arrow is filing this Amendment to add Exhibit 97.1, the Arrow Financial Corporation Clawback Policy (Adopted as of December 1, 2023), which was inadvertently omitted from the Original Filing. There were no changes made to the Arrow Financial Corporation Clawback Policy during 2025.
Except as described above, no other changes have been made to the Original Filing. The Original Filing continues to speak as of and for the periods covered in the Original Filing, and the Company has not updated the disclosures contained therein to reflect any subsequent events.

EXHIBIT INDEX

The following exhibits are incorporated by reference herein.
Exhibit
Number
Exhibit
3.(i)
3.(ii)
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
10.1
10.2
10.3
10.4
10.5



Exhibit
Number
Exhibit
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
14
16.1
19.1
21
23.1
23.2
31.1
31.2
32
97.1

The following exhibits are submitted herewith:



Exhibit
Number
Exhibit
31.3
31.4
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
XBRL Taxonomy Extension Labels Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Management contracts or compensation plans required to be filed as an exhibit.






Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

ARROW FINANCIAL CORPORATION

Date:March 27, 2026
By:   /s/ David S. DeMarco
David S. DeMarco
President and Chief Executive Officer
(Principal Executive Officer)
Date:March 27, 2026
By:   /s/ Penko Ivanov
Penko Ivanov
Chief Financial Officer
(Principal Financial and Accounting Officer)


Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below on March 6, 2026 by the following persons in the capacities indicated.



From this filing to the analytics

The analytics layer on top of every filing.

Boardroom Alpha scores every director and executive, tracks pay-for-performance, surfaces risk-factor changes, and forecasts every annual meeting — on every U.S. public company.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Arrow Financial Corp (AROW)

Reference

Frequently asked questions

When did Arrow Financial Corp file this 10-K/A?
Arrow Financial Corp (AROW) filed this Amended Annual Report (Form 10-K/A) with the SEC on March 27, 2026. The accession number assigned by EDGAR is 0000717538-26-000041.
What does a 10-K/A disclose?
Form 10-K is the SEC's annual report. Public companies use it to disclose audited financial statements, risk factors, management's discussion and analysis (MD&A), executive compensation, board-of-director information, and a comprehensive description of the business. It is the most-detailed disclosure document a U.S. issuer files each year.
Where can I find the risk factors and MD&A in this 10-K?
Risk factors appear in Item 1A and Management's Discussion and Analysis in Item 7 of the filing text above. The financial statements (Item 8) include the income statement, balance sheet, cash-flow statement, and notes.
Where can I find Arrow Financial Corp's prior annual reports on EDGAR?
The SEC EDGAR browser lists every 10-K/A Arrow Financial Corp has filed under CIK 717538, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer